Equity Fund
INVEST INTO AN A-CLASS PORTFOLIO
Anuva’s core objective is to grow wealth; for both investors and the companies in which we invest. The Anuva Equity Fund’s goal is to support portfolio companies to deliver market beating returns by generating both capital gains and dividends.
Our A-class portfolio is made up of seven established, small-to-medium sized enterprises with a combined Assets Under Management (AUM) of over R200 million. The portfolio is uniquely consumer facing and, having successfully navigated the economic headwinds of the COVID pandemic, is well-positioned to deliver strong returns.
Equity Fund
INVEST INTO AN A-CLASS PORTFOLIO
Anuva’s core objective is to grow wealth; for both investors and the companies in which we invest. The Anuva Equity Fund’s goal is to support portfolio companies to deliver market beating returns by generating both capital gains and dividends.
Our A-class portfolio is made up of seven established, small-to-medium sized enterprises with a combined Assets Under Management (AUM) of over R200 million. The portfolio is uniquely consumer facing and, having successfully navigated the economic headwinds of the COVID pandemic, is well-positioned to deliver strong returns.
A WORD FROM OUR CEO, NEILL HOBBS
A WORD FROM OUR CEO, NEILL HOBBS
About your investment
Biodelta
Anuva has a 10% stake in Biodelta valued at R10m
The Anuva Equity Fund is in a joint venture with Biodelta with the intention to convert to 10% equity. Biodelta operates as a contract manufacturing company. They develop and manufacture nutraceutical products such as capsules, tablets, powders, granules, effervescent sachets and tea. Biodelta serves the health and food industry. The company has recently extended its product range and manufacturing focus to deliver much-needed COVID-19 key products, such as virus test kits, three-layer surgical masks, sanitisers and immune booster supplements.
Biodelta
Anuva has a 10% stake in Biodelta valued at R10m
The Anuva Equity Fund is in a joint venture with Biodelta with the intention to convert to 10% equity. Biodelta operates as a contract manufacturing company. They develop and manufacture nutraceutical products such as capsules, tablets, powders, granules, effervescent sachets and tea. Biodelta serves the health and food industry. The company has recently extended its product range and manufacturing focus to deliver much-needed COVID-19 key products, such as virus test kits, three-layer surgical masks, sanitisers and immune booster supplements.
Cape Mohair
Anuva has a 69% stake in Cape Mohair valued at R22m
Anuva recently furthered its 46% stake in Cape Mohair Ltd to 69%. Established in 1991 and based in Cape Town, Cape Mohair is a proudly South African manufacturer of mohair socks. Their range includes medical, outdoor, workwear and leisure socks. Cape Mohair is proud to manufacture a product that is not just technologically advanced, but also creates jobs, supports local farming communities and treads lightly on the earth.
Cape Mohair
Anuva has a 69% stake in Cape Mohair valued at R22m
Anuva recently furthered its 46% stake in Cape Mohair Ltd to 69%. Established in 1991 and based in Cape Town, Cape Mohair is a proudly South African manufacturer of mohair socks. Their range includes medical, outdoor, workwear and leisure socks. Cape Mohair is proud to manufacture a product that is not just technologically advanced, but also creates jobs, supports local farming communities and treads lightly on the earth.
MasterCare
Anuva has a 69% stake in MasterCare valued at R36m
Established in 1974 as Early Bird, with more than 40 years as a proudly South African company, MasterCare is the leading name in home appliance repairs and maintenance. Their services encompass the installation, servicing and repair of home appliances. They also service the retail trade in and out of warranty period, providing end-user maintenance care plans, as well as value added products to leading brands and retail chains.
MasterCare
Anuva has a 69% stake in MasterCare valued at R36m
Established in 1974 as Early Bird, with more than 40 years as a proudly South African company, MasterCare is the leading name in home appliance repairs and maintenance. Their services encompass the installation, servicing and repair of home appliances. They also service the retail trade in and out of warranty period, providing end-user maintenance care plans, as well as value added products to leading brands and retail chains.
NuMobile
Anuva has a 69% stake in NuMobile valued at R64m
Founded in 2008, NuMobile is a leading smartphone provider to low-income workers in South Africa. Their goal is to provide employees with the necessary smart mobile technology for effective communication with their employers and colleagues. NuMobile aims to offer employees reliable and affordable smartphones with the aid of their employer at no risk to the employer.
NuMobile
Anuva has a 69% stake in NuMobile valued at R64m
Founded in 2008, NuMobile is a leading smartphone provider to low-income workers in South Africa. Their goal is to provide employees with the necessary smart mobile technology for effective communication with their employers and colleagues. NuMobile aims to offer employees reliable and affordable smartphones with the aid of their employer at no risk to the employer.
Mastercare Enterprises
Anuva has a 49% stake in Mastercare Enterprises valued at R4m
Mastercare Enterprises is a business that supplies medical orthopaedic and prosthetic products throughout South Africa. Their quality, custom-made range is fast making them a preferred supplier in their field. They specialise in orthopaedic bracing. bespoke manufacturing, prosthetic suspension technology, rehab/ therapy products, compression/ support garments, icing and recovery products and foot orthotic technology.
Mastercare Enterprises
Anuva has a 49% stake in Mastercare Enterprises valued at R4m
Mastercare Enterprises is a business that supplies medical orthopaedic and prosthetic products throughout South Africa. Their quality, custom-made range is fast making them a preferred supplier in their field. They specialise in orthopaedic bracing. bespoke manufacturing, prosthetic suspension technology, rehab/ therapy products, compression/ support garments, icing and recovery products and foot orthotic technology.
ARA
Anuva has a 4% stake in ARA valued at R1m
ARA is a soap manufacturer on a quest to make traditional practices and medicine more accessible and current. The company has a unique approach-they use indigenous medicinal plants as key ingredient in their soap formula, which is specifically developed for South African skin. ARA’s current range of quality Imphepho soap products targets the local mass market, and they engage small-scale farmers to grow and become long-term suppliers of Imphepho.
ARA
Anuva has a 4% stake in ARA valued at R1m
ARA is a soap manufacturer on a quest to make traditional practices and medicine more accessible and current. The company has a unique approach-they use indigenous medicinal plants as key ingredient in their soap formula, which is specifically developed for South African skin. ARA’s current range of quality Imphepho soap products targets the local mass market, and they engage small-scale farmers to grow and become long-term suppliers of Imphepho.
Sexy Socks
Anuva has a 10% stake in Sexy Socks valued at R1m
Sexy Socks is a fashion sock brand famous for their fun socks made from bamboo – a great fibre, which is not only kinder to the environment, but it is also antibacterial, anti-odour, hypoallergenic, and soft. Recently they expanded their range to include premium combed cotton socks and Sexy Jocks, bringing the unmistakable Sexy Socks splash of fun to ordinarily dull wardrobe staples. Sexy Socks believes in doing good business and care is put into every aspect of production – from conceptualisation through to product design, yarn selection and businesses practices. Through their one-for-one model, the business donates a pair of school socks to a child in need for every pair of Sexy Socks sold.
Sexy Socks
Anuva has a 10% stake in Sexy Socks valued at R1m
Sexy Socks is a fashion sock brand famous for their fun socks made from bamboo – a great fibre, which is not only kinder to the environment, but it is also antibacterial, anti-odour, hypoallergenic, and soft. Recently they expanded their range to include premium combed cotton socks and Sexy Jocks, bringing the unmistakable Sexy Socks splash of fun to ordinarily dull wardrobe staples. Sexy Socks believes in doing good business and care is put into every aspect of production – from conceptualisation through to product design, yarn selection and businesses practices. Through their one-for-one model, the business donates a pair of school socks to a child in need for every pair of Sexy Socks sold.
Fund management
Meet your Equity Fund Manager, Simon Berrange
I was lucky enough to be born, bred and schooled in Cape Town and I am a UCT graduate. My professional career has been cemented in the financial services sector, with most of my successes emerging from private equity and corporate finance. As a relatively new member to the dynamic Anuva team, I was very happy to land the A-Class/ Equity fund as my portfolio to manage; a field in which I am very comfortable.
Exit strategy
There are a number of potential events which will have an impact on the future exit from this fund.
Listing
It is the intention of the directors of Anuva to list the Anuva Equity Fund as a Private Equity fund on the Johannesburg Stock Exchange, or comparable exchange. The timing of this listing will be dependent upon the economic circumstances being favourable for the listing of a Private Equity Company and, of course, the track record of the Anuva Equity Fund.
This will undoubtedly be the most convenient option for investors to exit their investment as they can choose how many shares to sell, when and at what price.
If there is no Listing
Shareholders may exit by offering their shares to Anuva for repurchase. Shares will then be sold at the price determined by external valuation, subject to Anuva’s ability to redeem shares for cash. Typically, small parcels of shares will be able to be repurchased from within Anuva’s cash resources, whereas the repurchase of larger volumes of shares will only be able to be repurchased from the proceeds of fresh share subscriptions, or upon the exit from an underlying investment.
Shareholders wishing to sell their shares should give the directors of Anuva as much lead time as possible, ideally six months, of their intention to sell their shares.
Winding up of the Fund
The directors, acting on a resolution by the shareholders, may elect to wind up the fund by disposing of the underlying assets and paying the proceeds out to shareholders as a return of share capital.
This will obviously be done at the appropriate time and in consultation with the Investment Committee and the Shareholders.
Listing
It is the intention of the directors of Anuva to list the Anuva Equity Fund as a Private Equity fund on the Johannesburg Stock Exchange, or comparable exchange. The timing of this listing will be dependent upon the economic circumstances being favourable for the listing of a Private Equity Company and, of course, the track record of the Anuva Equity Fund.
This will undoubtedly be the most convenient option for investors to exit their investment as they can choose how many shares to sell, when and at what price.
If there is no Listing
Shareholders may exit by offering their shares to Anuva for repurchase. Shares will then be sold at the price determined by external valuation, subject to Anuva’s ability to redeem shares for cash. Typically, small parcels of shares will be able to be repurchased from within Anuva’s cash resources, whereas the repurchase of larger volumes of shares will only be able to be repurchased from the proceeds of fresh share subscriptions, or upon the exit from an underlying investment.
Shareholders wishing to sell their shares should give the directors of Anuva as much lead time as possible, ideally six months, of their intention to sell their shares.
Winding up of the Fund
The directors, acting on a resolution by the shareholders, may elect to wind up the fund by disposing of the underlying assets and paying the proceeds out to shareholders as a return of share capital.
This will obviously be done at the appropriate time and in consultation with the Investment Committee and the Shareholders.
Enquire Now
Fill in the form below and we will get back to you
Enquire Now
Fill in the form below and we will get back to you